Alperen Ozalp

Director, Product Strategy | MedTech | PE | VC | Software | Digital Health | MBA |

📍 United States🔄 Updated October 2026💼 1 investments📅 4 years investing🗓 Last invested Jan 2022
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 2 entries
All (2)
Investments (1)
2024
Advisor
Jul 2024
Quadria Capital is an Asian healthcare focused private equity firm with assets under management of over US$3.4 billion, maximising returns by investing in the high growth healthcare sector of some of the world’s fastest growing economies in South Asia and Southeast Asia, including Healthcare Delivery, Life Sciences, Medical Technology and Associated Healthcare Services subsectors. The firm aims to create significant and sustainable shareholder value by supporting strong, professionally run, stable and scalable healthcare organisations to address the critical and undersupplied healthcare needs in Asia. Further, Quadria Capital believes that its goals of both “doing good” and “doing well” are not just compatible, but in fact, mutually reinforcing. By incorporating a consideration of environmental, social and corporate governance impact into investment decisions and portfolio company management, Quadria Capital aims to make a positive, transformative impact in Asia’s healthcare sector, above and beyond significant financial returns for its investors.
2022
Angel Investor
Jan 2022
Life Science Angels (LSA) is the premier angel investing organization in the US, focused on investing exclusively in the life sciences. Since 2005, LSA has invested in 100+ companies in medical technology and biotechnology investment opportunities.